The spirometry market is experiencing notable growth, driven in part by the increasing demand for asthma spirometry devices. Asthma spirometry plays a crucial role in the diagnosis and management of asthma, a chronic respiratory condition characterized by airway inflammation and narrowing. Spirometry tests measure lung function by assessing the volume and flow of air that can be exhaled forcibly after a deep breath. These tests help healthcare professionals evaluate lung function, monitor disease progression, and determine the effectiveness of asthma treatments. With advancements in spirometry technology, asthma spirometry devices offer improved accuracy, portability, and ease of use, empowering patients and clinicians to better manage asthma and improve patient outcomes. As awareness about asthma and its management continues to grow, the demand for asthma spirometry devices is expected to drive further growth in the spirometry market.

Spirometry Market Size was valued at USD 1.93 billion in 2022 and is projected to grow from USD 0.6 Billion in 2023 to USD 1.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9% during the forecast period (2023 - 2030). 

Market Drivers and Restraints:

• Drivers:
  • Rise in prevalence of lung disorders due to factors like increasing pollution, changing lifestyle, and tobacco smoking addiction.
  • Introduction of advanced, compact, and easy-to-use medical devices.
  • Increased healthcare expenditure globally.
• Restraints:
  • Lack of awareness and low penetration of technologically advanced healthcare solutions.

Market Segmentation:

• Product:
  • Table-top spirometry
  • Hand-held spirometry
  • Desktop (PC) spirometry
• Technology:
  • Volume measurement spirometry
  • Peak flow meters (PFM)
  • Flow measurement spirometry
    • Pneumotachograph system
    • Mass flow meter
• Application:
  • Diagnostic
    • COPD
    • Asthma
    • Interstitial pulmonary fibrosis
  • Treatment monitoring
• End-users:
  • Research & academic institutes
  • Diagnostic centers
  • Hospitals & clinics
  • Home care

Regional Analysis:

• Americas:
  • Major share due to easy adoption of advanced medical devices, high prevalence of pulmonary disorders, and high healthcare expenditure.
• Europe:
  • Significant growth rate due to high demand for advanced spirometers in well-developed healthcare sector and proliferation of asthma cases.
• Asia Pacific:
  • Notable growth rate due to increasing awareness regarding lung disorders, adoption of advanced healthcare solutions, and high prevalence of lung disorders.
• Middle East and Africa:
  • Driven by improvement in healthcare infrastructure and enhanced healthcare budget.

Within the spirometry market, breathing spirometers are essential devices used to assess lung function and respiratory health in various clinical settings. A breathing spirometer measures the volume of air inspired and expired by the lungs, providing valuable information about lung capacity, respiratory muscle strength, and breathing patterns. These tests are commonly used in preoperative evaluations, pulmonary rehabilitation programs, and intensive care units to monitor respiratory function and optimize patient care. With user-friendly designs and digital interfaces, breathing spirometers enable patients to perform lung function tests with ease and accuracy, facilitating early detection of respiratory abnormalities and guiding personalized treatment plans. As healthcare providers continue to prioritize respiratory health and disease prevention, the demand for breathing spirometers is expected to drive innovation and growth in the spirometry market, improving patient outcomes and quality of life.

Key Players:

The leading Spirometry companies profiled by MRFR that are operating in the global spirometry market are Carefusion Corporation (the U.S.), NDD Medical Technologies, Inc. (the U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (the U.S.), Vitalograph (the U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (the U.S.), Midmark Corporation (the U.S.), Smiths Medical Inc. (the U.S.), and Koninklijke Philips N.V. (The Netherlands).

For more information visit at MarketResearchFuture